Suggestions(1)
Exact(7)
Women aged 40 to 74 years with baseline mammograms (n = 50,599) were included.
The other two male participants were aged 62 and 64 years with baseline MMSE scores of 22 and 20, respectively.
Yaffe and colleagues [ 29] followed 5,925 women (more than 65 years old) for 6 to 8 years with baseline selfreport exercise measures.
Each examination cycle spanned 2 years, with baseline (2000 2002) and three follow-up examinations conducted from 2002 2003, 2004 2005, and 2005 2007.
Patients (aged ≥ 40 years with baseline FEV1 ≤ 65% predicted, FEV1 > 0.50 L, FEV1/FVC ≤ 70%, and ≥ 15 pack-year smoking history) received arformoterol (n = 420) or placebo (n = 421) for 1 year.
Patients aged ≥ 18 years with baseline estimation of glomerular filtration rate (eGFR) < 60 mL/min, as measured in their most recent sample and at least two measurements for ≥ three months prior to the beginning of the protocol, were included in the study.
Similar(52)
Mean weight loss at one year, with baseline value used for imputation, was 0.8 (SD 4.7) kg for primary care and 2.5 (6.2) kg for commercial programmes.
Changes in absolute CVD risk were similar in both groups, showing about a 10% reduction from mean baseline score, corresponding to relative risks of 0.89 (0.87 – 0.92) in the Health Check only group and 0.91 (0.88 – 0.94) in the Health Check plus additional lifestyle support group (comparing scores at 1 year with baseline).
Ziegler et al. [25] demonstrated that both TDR and fusion treatment groups obtain significant improvement in ODI at 5 years compared with baseline.
An intention-to-treat analysis showed statistically significant improvements in both groups at five years compared with baseline.
There was also improvement in the lipid profile of patients at the end of 10 years compared with baseline.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com